744 related articles for article (PubMed ID: 22145712)
21. Validation of psoriasis disability index (PDI) questionnaire Sinhala version.
Liyanage A; Liyanage G; De Silva V; Akarawita J; Gunasekera C; Imafuku S; Lekamwasam S
Arch Dermatol Res; 2022 Jan; 314(1):61-69. PubMed ID: 33675385
[TBL] [Abstract][Full Text] [Related]
22. An adapted Chinese version of neck pain and disability scale: validity and reliability.
Chen Z; Zhao Y; Wang C; Li M; Zhu X
Spine (Phila Pa 1976); 2011 Sep; 36(20):E1322-7. PubMed ID: 21358467
[TBL] [Abstract][Full Text] [Related]
23. Health-related quality of life in psoriasis: an analysis of Psocare project patients.
Spandonaro F; Altomare G; Berardesca E; Calzavara-Pinton P; Chimenti S; Girolomoni G; Peserico A; Guerra AP; Vena GA; Polistena B; Ayala F
G Ital Dermatol Venereol; 2011 Jun; 146(3):169-77. PubMed ID: 21566546
[TBL] [Abstract][Full Text] [Related]
24. Psoriasis affects patient's quality of life more seriously in female than in male in Japan.
Mabuchi T; Yamaoka H; Kojima T; Ikoma N; Akasaka E; Ozawa A
Tokai J Exp Clin Med; 2012 Sep; 37(3):84-8. PubMed ID: 23032250
[TBL] [Abstract][Full Text] [Related]
25. Durable dermatology life quality index improvements in patients on biologics associated with psoriasis areas and severity index: a longitudinal study.
Chaptini C; Quinn S; Marshman G
Australas J Dermatol; 2016 Aug; 57(3):e72-5. PubMed ID: 26010650
[TBL] [Abstract][Full Text] [Related]
26. Life quality of Chinese patients with chronic urticaria as assessed by the dermatology life quality index.
Liu JB; Yao MZ; Si AL; Xiong LK; Zhou H
J Eur Acad Dermatol Venereol; 2012 Oct; 26(10):1252-7. PubMed ID: 21958389
[TBL] [Abstract][Full Text] [Related]
27. Ustekinumab improves health-related quality of life in patients with moderate-to-severe psoriasis: results from the PHOENIX 1 trial.
Lebwohl M; Papp K; Han C; Schenkel B; Yeilding N; Wang Y; Krueger GG
Br J Dermatol; 2010 Jan; 162(1):137-46. PubMed ID: 19903183
[TBL] [Abstract][Full Text] [Related]
28. Life quality among psoriasis patients based on Dermatology Life Quality Index evaluation and its association with psoriasis severity in China: a cross-sectional study.
Chen Y; Wei L; Song Y; Zhang R; Kuai L; Li B; Wang R
Ann Med; 2023 Dec; 55(1):2231847. PubMed ID: 37417705
[TBL] [Abstract][Full Text] [Related]
29. Decision for biological treatment in real life is more strongly associated with the Psoriasis Area and Severity Index (PASI) than with the Dermatology Life Quality Index (DLQI).
Hägg D; Sundström A; Eriksson M; Schmitt-Egenolf M
J Eur Acad Dermatol Venereol; 2015 Mar; 29(3):452-6. PubMed ID: 24911993
[TBL] [Abstract][Full Text] [Related]
30. Quality of life instrument for Turkish people with skin diseases.
Gurel MS; Yanik M; Simsek Z; Kati M; Karaman A
Int J Dermatol; 2005 Nov; 44(11):933-8. PubMed ID: 16336527
[TBL] [Abstract][Full Text] [Related]
31. Effect of vitiligo on self-reported health-related quality of life.
Ongenae K; Van Geel N; De Schepper S; Naeyaert JM
Br J Dermatol; 2005 Jun; 152(6):1165-72. PubMed ID: 15948977
[TBL] [Abstract][Full Text] [Related]
32. Psychometric properties of the simplified Chinese version of the EORTC QLQ-BR53 for measuring quality of life for breast cancer patients.
Wan C; Tang X; Tu XM; Feng C; Messing S; Meng Q; Zhang X
Breast Cancer Res Treat; 2007 Oct; 105(2):187-93. PubMed ID: 17221159
[TBL] [Abstract][Full Text] [Related]
33. Impact of active and stable psoriasis on health-related quality of life: the PSO-LIFE study.
Daudén E; Herrera E; Puig L; Sánchez-Carazo JL; Toribio J; Perulero N
Actas Dermosifiliogr; 2013 Oct; 104(8):685-93. PubMed ID: 23958428
[TBL] [Abstract][Full Text] [Related]
34. Psychometric validation of the French version of the quality of life in epilepsy inventory (QOLIE-31): comparison with a generic health-related quality of life questionnaire.
Picot MC; Crespel A; Daurès JP; Baldy-Moulinier M; El Hasnaoui A
Epileptic Disord; 2004 Dec; 6(4):275-85. PubMed ID: 15634625
[TBL] [Abstract][Full Text] [Related]
35. Improvement in quality of life with infliximab induction and maintenance therapy in patients with moderate-to-severe psoriasis: a randomized controlled trial.
Reich K; Nestle FO; Papp K; Ortonne JP; Wu Y; Bala M; Evans R; Guzzo C; Li S; Dooley LT; Griffiths CE
Br J Dermatol; 2006 Jun; 154(6):1161-8. PubMed ID: 16704649
[TBL] [Abstract][Full Text] [Related]
36. Reliability and validity of a Chinese version of the Quality of Life in Epilepsy Inventory (QOLIE-89).
Zhao Y; Ding C; Wang Y; Li Z; Zhou Y; Huang Y
Epilepsy Behav; 2007 Aug; 11(1):53-9. PubMed ID: 17499025
[TBL] [Abstract][Full Text] [Related]
37. Measuring health-related quality of life in patients with mild to moderate eczema and psoriasis: clinical validity, reliability and sensitivity to change of the DLQI. The Cavide Research Group.
Badia X; Mascaró JM; Lozano R
Br J Dermatol; 1999 Oct; 141(4):698-702. PubMed ID: 10583119
[TBL] [Abstract][Full Text] [Related]
38. Psychometric properties of the Chinese version of the SF-36 in older adults with diabetes in Beijing, China.
Hu J; Gruber KJ; Hsueh KH
Diabetes Res Clin Pract; 2010 Jun; 88(3):273-81. PubMed ID: 20392508
[TBL] [Abstract][Full Text] [Related]
39. Cultural adaptation and application of the IBS-QOL in China: a disease-specific quality-of-life questionnaire.
Huang WW; Zhou FS; Bushnell DM; Diakite C; Yang XH
Qual Life Res; 2007 Aug; 16(6):991-6. PubMed ID: 17440830
[TBL] [Abstract][Full Text] [Related]
40. Measurement properties of a patient-reported outcome measure assessing psoriasis severity: The psoriasis symptoms and signs diary.
Mathias SD; Feldman SR; Crosby RD; Colwell HH; McQuarrie K; Han C
J Dermatolog Treat; 2016 Aug; 27(4):322-7. PubMed ID: 26634943
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
